The next step in the evolution of peptides for metabolism.
While Semaglutide works with one hormone and Tirzepatide with two, Retatrutide was designed to act on three natural systems of the body. This is why many researchers consider it one of the most promising molecules in the field of metabolism.
What is it?
Retatrutide is a peptide that activates three different receptors:
• GLP-1
• GIP
• Glucagon Each one plays a distinct role in the body's energy balance.
In short:
• It combines three natural signals into a single molecule.
How does it work?
After eating, the body uses different hormones to regulate hunger, glucose, and energy use.
Retatrutide was designed to activate three of those pathways simultaneously.
It's like upgrading from a two-cylinder engine to a three-cylinder one: more systems working in coordination.
What is science researching?
• Appetite regulation
• Body weight management
• Glucose control
• Energy expenditure
• Metabolic health
What results have studies observed?
Research is still ongoing, but trends reported include:
• Increased feeling of fullness.
• Reduced appetite.
• Significant changes in body weight in some clinical studies.
• Improvements in various metabolic markers in studied populations.
More research is needed to fully understand its long-term effects.
What makes Retatrutide different?
Its main difference is that it combines three mechanisms of action into a single peptide.
GLP-1 Helps regulate appetite and glucose.
GIP Participates in the metabolic response after eating.
Glucagon Is being researched for its potential role in energy expenditure and metabolism.
The combination of these three pathways has generated great scientific interest.
What does it NOT do?
• It does not replace healthy habits.
• It does not eliminate the need for medical follow-up when appropriate.
• It does not guarantee the same results for everyone.
• It remains a compound under investigation for various potential applications.
Why so much expectation?
Because it represents a new generation of peptides that seek to understand metabolism from multiple angles at the same time, rather than acting on a single hormonal pathway.
Interesting fact
• Retatrutide is known as a triple agonist, as it interacts with three different receptors in a single molecule.
Until a few years ago, this combination did not exist in a single peptide.
Is this peptide for you?
If you are interested in learning about:
• Advanced metabolism.
• Obesity research.
• Appetite regulation.
• Energy expenditure.
• New generations of peptides.
Retatrutide is one of the most innovative compounds to know.
Did you know?
Retatrutide is still in clinical research and does not yet have general regulatory approvals for medical use. This is precisely why it is one of the most observed compounds by the scientific community: its studies aim to determine both its efficacy and safety before any broader use.
Product intended for research use only (For Research Use Only). The information is educational and does not constitute medical advice, diagnosis, or treatment.
While Semaglutide works with one hormone and Tirzepatide with two, Retatrutide was designed to act on three natural systems of the body. This is why many researchers consider it one of the most promising molecules in the field of metabolism.
What is it?
Retatrutide is a peptide that activates three different receptors:
• GLP-1
• GIP
• Glucagon Each one plays a distinct role in the body's energy balance.
In short:
• It combines three natural signals into a single molecule.
How does it work?
After eating, the body uses different hormones to regulate hunger, glucose, and energy use.
Retatrutide was designed to activate three of those pathways simultaneously.
It's like upgrading from a two-cylinder engine to a three-cylinder one: more systems working in coordination.
What is science researching?
• Appetite regulation
• Body weight management
• Glucose control
• Energy expenditure
• Metabolic health
What results have studies observed?
Research is still ongoing, but trends reported include:
• Increased feeling of fullness.
• Reduced appetite.
• Significant changes in body weight in some clinical studies.
• Improvements in various metabolic markers in studied populations.
More research is needed to fully understand its long-term effects.
What makes Retatrutide different?
Its main difference is that it combines three mechanisms of action into a single peptide.
GLP-1 Helps regulate appetite and glucose.
GIP Participates in the metabolic response after eating.
Glucagon Is being researched for its potential role in energy expenditure and metabolism.
The combination of these three pathways has generated great scientific interest.
What does it NOT do?
• It does not replace healthy habits.
• It does not eliminate the need for medical follow-up when appropriate.
• It does not guarantee the same results for everyone.
• It remains a compound under investigation for various potential applications.
Why so much expectation?
Because it represents a new generation of peptides that seek to understand metabolism from multiple angles at the same time, rather than acting on a single hormonal pathway.
Interesting fact
• Retatrutide is known as a triple agonist, as it interacts with three different receptors in a single molecule.
Until a few years ago, this combination did not exist in a single peptide.
Is this peptide for you?
If you are interested in learning about:
• Advanced metabolism.
• Obesity research.
• Appetite regulation.
• Energy expenditure.
• New generations of peptides.
Retatrutide is one of the most innovative compounds to know.
Did you know?
Retatrutide is still in clinical research and does not yet have general regulatory approvals for medical use. This is precisely why it is one of the most observed compounds by the scientific community: its studies aim to determine both its efficacy and safety before any broader use.
Product intended for research use only (For Research Use Only). The information is educational and does not constitute medical advice, diagnosis, or treatment.
Specifications
| SKU | PEP-013 |
|---|---|
| Brand | 45PRIME |
| Unit of measure | UNIDAD |
| Category | Metabolism |
| Type | Triple agonist |
| Function | Activates GLP-1, GIP, and glucagon |
| Main research area | Body weight, metabolism and glucose |
| State | In clinical research |
| Presentation | Vial 20 mg |
| Categories | WEIGHT LOSS |
There are no reviews for this product yet.
Write your review
Sign in to leave a review.
There are no questions about this product yet. Be the first to ask!
Sign in to ask a question about this product.
Work out the concentration and how many units to draw on the syringe for the water you add.
mg
ml
Fill in the three fields to see the result.
Concentration
mg/ml
Volume to draw
ml
Mark on the syringe
units
Doses per vial
doses
The requested dose is larger than what the vial holds.
Research use only. This tool merely calculates the dilution from the figures you enter: it is not a dose recommendation or a use indication.
You might also like
RETATRUTIDE Vial 20 mg
Sign in to see the price